A 12-year study examines long-term urinary incontinence after OASIS and vaginal birth. Learn how symptoms and quality of life change over time. Read more.

West Tennessee Healthcare is pleased to announce a new treatment option for people living with urge urinary incontinence (UUI ...

Mission Health announces successful completion of groundbreaking pilot program at McPherson Health & Rehab, using ...

On January 6, JPMorgan reiterated Boston Scientific Corporation (NYSE:BSX) is one of its top pick stocks in the healthcare ...

After suffering in silence, these women are relying on a pessary and the results have been life-changing. What to know about ...

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...

Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an ...

Study demonstrates superior biocompatibility and mechanical performance of the Plielle™ urethral support system. For ...

MOUNTAIN VIEW , CA, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Renaissance Healthcare for Women, led by ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...